CGEM Investing Cash Flow

Cullinan Therapeutics Inc · Investing Cash Flow

CGEM logo

CGEM Investing Cash Flow

Latest reported$162.88M
CGEM Cash from Investing (-$261.00K → $162.88M)
High-resolution chart · PNG

CGEM investing cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cullinan Therapeutics Inc Investing Cash Flow — Annual fiscal periods (USD)
Period endingInvesting Cash Flow (USD)
179,989,000
-136,314,000
35,806,000
248,975,000
-333,775,000
-5,420,000
-35,400,000
-261,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.